missing translation for 'onlineSavingsMsg'
Learn More
Learn More
LAG-3 Antibody (L4-PL33) - BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
£224.00 - £499.00
Specifications
| Antigen | LAG-3 |
|---|---|
| Clone | L4-PL33 |
| Classification | Monoclonal |
| Conjugate | Unconjugated |
| Form | Purified |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
18612664
|
Novus Biologicals
NBP3-23442-100ug |
100 μg |
£499.00
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18621544
|
Novus Biologicals
NBP3-23442-50ug |
50 μg |
£346.00
50µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18651334
|
Novus Biologicals
NBP3-23442-25ug |
25 ug |
£224.00
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
LAG-3 Monoclonal antibody specifically detects LAG-3 in Human, Primate samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), NeutralizationSpecifications
| LAG-3 | |
| Monoclonal | |
| Purified | |
| RUO | |
| Human, Primate | |
| 17b4, 17b4 lag3, 17b4 neutralizing, anti human lag3, Anti-LAG-3, CD223, CD223 Antigen, Human LAG3, Human LAG-3, LAG3, LAG-3, LAG-3 17b4, LAG-3 blocking, lymphocyte activating 3, lymphocyte activation gene 3 protein, lymphocyte-activation gene 3, Secreted lymphocyte activation gene 3 protein, sLAG-3 | |
| This LAG-3 Antibody (L4-PL33) was prepared from synthetic peptide corresponding to 30 aa (GPPAAAPGHPLAPGPHPAAPSSWGPRPRRY) from the first N-terminal D1 domain of human LAG-3 (lymphocyte activation gene-3). | |
| Protein A or G purified |
| L4-PL33 | |
| Unconjugated | |
| Mouse | |
| Adaptive Immunity, Cancer, Immunology, Innate Immunity | |
| PBS, 10% glycerol | |
| 3902 | |
| Primary |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title